US Patent Issued to Protokinetix on Jan. 13 for "Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome" (Canadian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,419, issued on Jan. 13, was assigned to Protokinetix Inc. (St. Mary's, W.va.).

"Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome" was invented by Lachlan Grant Young (Nanimo, Canada) and A.M. James Shapiro (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an in vitro method for enhancing engraftment of isolated pancreatic cells comprising the step of contacting an isolated pancreatic cell prior to a transplantation in a subject in need thereof, with a gem-difluorinated C-glycopeptide compound of general formula I, or a pharmaceutically acceptab...